Ticking Of Body's 24-hour Clock Turns Gears Of Metabolism And Aging

Their findings can potentially explain why the waning of the circadian rhythm with age could contribute to age-related disorders such as insulin resistance and type 2 diabetes.

"Our study establishes a detailed scheme linking metabolism and aging to the circadian rhythm," says one of the lead authors, Shin-ichiro Imai, M.D., Ph.D., who researches aging at Washington University School of Medicine. "This opens the door to new avenues for treating age-related disorders and ways to restore a healthy daily circadian rhythm. It could also yield new interventions to alleviate metabolic disorders such as obesity and diabetes."

Imai, associate professor of medicine and of developmental biology, focuses on the molecular mechanisms of aging and longevity. Earlier, he demonstrated that a gene called SIRT1 was at the center of a network that regulates aging. A form of the gene is found in every organism on earth, and seven forms of the gene exist in humans.

SIRT1 has a broad reach, influencing glucose breakdown and production, cholesterol metabolism, fat burning and insulin sensitivity. Basically, the gene coordinates metabolic reactions throughout the body and manages the body's response to nutrition.

Interestingly, increasing the activity of proteins related to SIRT1 extends the life span of organisms such as yeast, worms and flies. SIRT1 is activated when calories are restricted below normal, which has been shown to extend the life spans of some laboratory animals. "Under nutritional scarcity, SIRT1 may delay aging and extend life span to assure survival until food becomes more readily available," Imai explains.

Imai's collaborator in the current study, Joseph Bass, M.D., Ph.D., assistant professor of medicine and neurobiology at Northwestern University, earlier demonstrated that interfering with the circadian clock of mice led to metabolic complications including obesity and type 2 diabetes.

Now their joint research, led by Kathryn Moynihan Ramsey, Ph.D., at Northwestern and Jun Yoshino, M.D., Ph.D., and Cynthia S. Brace, both at Washington University, has linked the circadian clock to SIRT1 through a key metabolite that serves as the energy currency of the body.

As a result, they have defined a biochemical mechanism by which the body's metabolic and nutritional status can directly drive the oscillation of the body's daily clock as well as influence aging and longevity. This new information points potentially to innovative ways to correct metabolic disorders and improve health as people age.

Studying laboratory mice, the researchers found a daily oscillation of the metabolite NAD (nicotinamide adenine dinucleotide), an important compound that is the body's way of exchanging energy and moving it where it's needed. Previously, scientists believed the amount of NAD in the body's cells stayed fairly constant.

"Seeing this striking abnormality in the NAD levels was like discovering the cause of a disease in a patient after running a blood test," Bass says.

Importantly, the researchers found that this NAD rhythm was linked to the daily rise and fall of the activity of "clock" genes, the genes that serve as the gears that run the body's internal clock. They discovered that the clock genes directly interact with a biochemical process that produces NAD.

NAD is required for SIRT1 to function, suggesting that SIRT1 activity increased and decreased along with NAD oscillation in the mice. Since SIRT1 is known to inhibit the clock genes, the cycle of its activity feeds back into the clock mechanism.

Studying the mice under controlled conditions of light and dark, the researchers established the details of the NAD-SIRT1-clock gene loop and showed that it functions in liver and fat cells. "We showed that this feedback cycle is driven by NAD," Imai says. "Because NAD levels reflect nutrition and energy levels, NAD's link to the circadian and aging mechanisms makes them sensitive to the nutritional status of the organism."

Next, Imai and members of his laboratory will look at whether manipulating components of the NAD biochemical pathway could have therapeutic effects on metabolism through insulin secretion and insulin sensitivity as well as on health in aging individuals.

Takahasi is a cofounder of ReSet Therapeutics Inc., and he and Bass are members of its scientific advisory board. Bass is an advisor and receives support from Amylin Pharmaceuticals. Imai holds a patent related to this research.

Funding from the National Institute of Diabetes and Digestive and Kidney Diseases, The National Institute on Aging, the Ellison Medical Foundation, the Longer Life Foundation, the National Institutes of Health, Chicago Biomedical Consortium Searle Funds, the Juvenile Diabetes Research Foundation, the Japan Research Foundation for Clinical Pharmacology, Keio University Medical Science Fund and the Howard Hughes Medical Institute supported this research.